91-105 of 123
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®Gout Beyond the Joints: What’s the Hidden Danger?
Richard Johnson, MD
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®Is Managing Gout in the Nephrology Clinic a Challenge?
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
Abdul Abdellatif, MD, FASN
Richard Johnson, MD
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®Center of the Target: Which Patients Are Most Likely to Develop Gout?
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
- MinuteCE®
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD
Abdul Abdellatif, MD, FASN
John K. Botson, MD, RPh
Brittany Weber, MD, PhD
Abdul Abdellatif, MD, FASN
Richard Johnson, MD
- advertisement
Should We Look for Gout in the Cardiology Clinic?
MinuteCE®Should We Look for Gout in the Cardiology Clinic?
Richard Johnson, MD
Brittany Weber, MD, PhD
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®Treat or Refer: Who Is Responsible for Managing Gout?
John K. Botson, MD, RPh
Abdul Abdellatif, MD, FASN
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
CME/CEA Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
Siân Griffin, MD, PhD
Jürgen Floege, MD
Loreto Gesualdo, MD, FERA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
CME/CEDirected Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Jonathan Barratt, MD, PhD
Annette Bruchfeld, MD, PhD
- advertisement
KALMing the Itch: Improving QoL in Patients with CKD-aP
CME/CEKALMing the Itch: Improving QoL in Patients with CKD-aP
Joel Topf, MD
Kieran McCafferty, MD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
CME/CEUnderstanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Jonathan Barratt, MD, PhD
Donald E. Kohan, MD, PhD
Separating Fact from Fiction: The Realities of CKD-aP
CME/CESeparating Fact from Fiction: The Realities of CKD-aP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
